StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2022 - 06 - 22
1
2021 - 11 - 18
1
2021 - 11 - 10
1
2021 - 03 - 18
1
Sector
Health technology
4
Tags
Acquire
7
Agreement
5
Application
6
Approval
7
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
6
Cardiovascular
5
Collaboration
8
Companies
6
Conference
20
Device
5
Diabetes
34
Disease
18
Drug
18
Earnings
8
Europe
10
Events
22
Expansion
7
Expected
10
Fda
11
Financial
7
Financial results
7
Genetown
7
Global
45
Growing
5
Growth
33
Hormone
7
Insulin
32
Iot
6
Kidney
5
Liver
11
Market
79
Money
8
N/a
520
Obesity
16
People
11
Pharma
81
Pharmaceutical
12
Phase 2
7
Phase 3
6
Program
10
Reach
10
Report
39
Repurchase
97
Research
34
Results
20
S
42
Sales
13
Sanofi
7
Study
6
Technology
10
Therapeutics
27
Therapy
11
Treatment
34
Trial
32
Trials
9
Update
12
Entities
Amgen inc.
1
Genfit s.a.
1
Gilead sciences, inc.
2
Intercept pharmaceuticals, inc.
1
Novo nordisk a/s
4
Symbols
ABCM
1
ADIL
1
AGM
1
AGNPF
4
AKRO
27
ALGS
11
ALNY
2
ALT
3
AMGN
1
ARVL
3
ARWR
2
ATNF
1
ATRX
1
AXLA
6
AZN
1
AZNCF
1
CANF
10
CBAY
1
CHH
1
CLOV
1
CMLS
7
CMMB
2
CWBR
6
CYDY
3
DRE
1
DRRX
2
ENSG
1
ENTA
1
ERIC
1
ETNB
11
FNCTF
2
GALT
10
GILD
3
GLMD
3
GNFT
6
GSK
1
HEPA
16
HTGC
2
ICPT
19
IVA
15
JNJ
2
LH
2
LPCN
12
MDGL
13
MNOV
5
MTCR
9
NRBO
5
NVO
4
NXST
2
OMC
2
ONVO
2
ORMP
7
REGN
2
SGMT
9
SNY
3
SNYNF
3
TAK
2
TEVJF
2
THTX
2
ZEAL
3
Exchanges
Nasdaq
2
Nyse
4
Crawled Date
2022 - 06 - 22
1
2021 - 11 - 18
1
2021 - 11 - 10
1
2021 - 03 - 18
1
Crawled Time
11:00
1
12:00
1
17:00
1
22:00
1
Source
www.biospace.com
3
www.globenewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Nash
symbols :
Nvo
save search
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Published:
2022-06-22
(Crawled : 11:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
19.0%
|
O:
-0.68%
H:
0.0%
C:
0.0%
partnership
nash
GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH
Published:
2021-11-18
(Crawled : 22:00)
- globenewswire.com
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
11.83%
|
O:
-0.36%
H:
0.3%
C:
-0.65%
ICPT
|
$19.0
-0.05%
4M
|
Health Technology
|
8.55%
|
O:
-1.54%
H:
2.15%
C:
0.06%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-1.12%
|
O:
0.59%
H:
1.04%
C:
0.74%
GNFT
|
$3.4449
-6.4%
3.5K
|
Health Technology
|
2.69%
|
O:
5.07%
H:
1.14%
C:
-0.27%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
34.08%
|
O:
0.61%
H:
0.45%
C:
0.39%
nis4
unique
risk
technology
nash
PathAI and Novo Nordisk present AI-powered scoring showing significant reduction of fibrosis following semaglutide treatment in patients with NASH
Published:
2021-11-10
(Crawled : 17:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
12.19%
|
O:
-0.9%
H:
0.32%
C:
-0.81%
treatment
ema
fibrosis
nash
Gilead and Novo Nordisk Expand NASH Clinical Collaboration
Published:
2021-03-18
(Crawled : 12:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
79.21%
|
O:
-1.43%
H:
0.99%
C:
0.23%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
4.05%
|
O:
-1.24%
H:
2.14%
C:
0.72%
collaboration
nash
expansion
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.